SCHEMBL31222429

SCHEMBL31222429

Clc1cc2ccc3ccccc3c2c2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 5/20 0.50
▸ ALDH1A1 P00352 4/20 0.48
▸ CYP1A2 P05177 5/20 0.48
▸ HSD17B10 Q99714 4/20 0.46
▸ TSHR P16473 2/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ L3MBTL1 Q9Y468 3/20 0.46
▸ MAPT P10636 1/20 0.46
▸ ERBB2 P04626 1/20 0.45
▸ FYN P06241 1/20 0.45
▸ MAOA P21397 1/20 0.45
▸ ACHE P22303 1/20 0.45
▸ AHR P35869 1/20 0.45
▸ HIF1A Q16665 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ CYP1B1 Q16678 1/20 0.44
▸ THRB P10828 1/20 0.44
▸ HPRT1 P00492 1/20 0.42
▸ CCR1 P32246 1/20 0.41
▸ CCR8 P51685 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24656655 1.00 CYP2A6 (0.50) CYP2A6ALDH1A1CYP1A2HSD17B10TSHR
SCHEMBL31222433 0.83 HSD17B10 (0.56) CYP2A6ALDH1A1CYP1A2HSD17B10TSHR
SCHEMBL24372659 0.83 HSD17B10 (0.56) CYP2A6ALDH1A1CYP1A2HSD17B10TSHR
SCHEMBL24655507 0.83 ALDH1A1 (0.50) CYP2A6ALDH1A1CYP1A2HSD17B10TSHR
SCHEMBL31222435 0.83 ALDH1A1 (0.50) CYP2A6ALDH1A1CYP1A2HSD17B10TSHR
SCHEMBL22211948 0.81 CYP1A2 (0.64) CYP2A6ALDH1A1CYP1A2HSD17B10TSHR
SCHEMBL30887598 0.81 CYP1A2 (0.64) CYP2A6ALDH1A1CYP1A2HSD17B10TSHR
SCHEMBL24156128 0.79 AHR (0.46) CYP2A6CYP1A2TDP1L3MBTL1MAPT
SCHEMBL22650690 0.79 CYP2A6 (0.42) CYP2A6ALDH1A1CYP1A2HSD17B10TSHR
SCHEMBL24066459 0.78 CYP2A6 (0.50) CYP2A6ALDH1A1CYP1A2HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240300926-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2024-09-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240300926-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CYP1A1, AHR, CYP1B1 CYP2A6 177/4885ALDH1A1 234/4885CYP1A2 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback